A meta-analysis assessing studies using the 3xTg-AD mouse [which contains amyloid and tau pathology, as well as mutations in Presenelin-1 (PS1)] showed that tau plays more of a role in cognitive decline than Aβ (Huber et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.